Lindbrook Capital, LLC - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 79 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$11,000
+1000.0%
1,562
+1616.5%
0.00%
Q4 2021$1,000910.00%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$124,994,0001.61%
Baker Brothers Advisors 10,123,824$126,042,0000.61%
Pinz Capital Management, LP 43,800$545,0000.21%
HHLR ADVISORS, LTD. 583,333$7,262,0000.11%
Rock Springs Capital Management LP 368,959$4,594,0000.11%
Nan Fung Group Holdings Ltd 20,350$253,0000.08%
Virtus ETF Advisers LLC 13,815$172,0000.06%
PDT Partners, LLC 35,907$447,0000.03%
Jump Financial, LLC 36,900$459,0000.03%
Parkwood LLC 12,667$158,0000.03%
View complete list of PRELUDE THERAPEUTICS INC shareholders